Exhilarating and sobering time at AAI 2025! Old and new colleagues, tremendous progress, great discussions. Going back to lab energized! #immunologymatters #changingwhatspossible biorxiv.org/content/10.110…

He's working to cure cancer AND he can throw a baseball! Hollings researcher Ferreira Lab recently threw out the first pitch at the Charleston RiverDogs as the health care hero of the game! Great job Dr. Ferreira! ⚾

Truly exciting to speak at UT Southwestern Medical Center on repurposing regulatory T cells for cancer therapy! A big thank you to Dr. Rolf Brekken and Iosif Gershteyn for the opportunity and Dr. John Minna for hosting. #immunologymatters #changingwhatspossible #CARTregs

Tremendous time at the Southeastern Immunology Symposium at the University of Virginia UVA in Charlottesville, VA! Phenomenal speakers and lively poster sessions at a beautiful campus and charming town. #immunologymatters #changingwhatspossible #SIS2025

June is #CancerImmunotherapyMonth – a celebration of advancements being made and the individuals driving innovation. The goal of Ferreira Lab at Hollings is to learn how to retrain the immune system to fight off the solid tumors. More: bit.ly/3Rut2rB

The Ferreira Lab turns 4 years old!!!! ferreiralab.com #immunologymatters #changingwhatspossible

Happy 4th of July everyone! Entering the 250th year of the United States of America!

Deeply honored to have been invited to speak at the American Diabetes Association (ADA) 2025 scientific sessions in Chicago. A scalable cure for type 1 diabetes is in sight! #immunologymatters #changingwhatspossible

Elated to speak, present three posters, and reconnect with colleagues at the Federation of Clinical Immunology Societies (FOCIS) annual meeting in Boston!!! FOCIS #immunologymatters #changingwhatspossible

Super proud of Burhan Rajnagarwala of the South Carolina Governor’s School for Science and Mathematics for completing his summer research internship and speaking on his work with Erin O’Connor in the lab. #immunologymatters #changingwhatspossible #CARTregs

Thank you Maynard Nexsen for the opportunity to speak on Taking the Pulse - A Health Care and Life Sciences Podcast about Torpedo Bio's work on tackling cancer with cellular immunotherapy! #immunologymatters youtube.com/watch?v=R1jxDJ…

Congratulations to Meghan Schreck on a super productive summer and excellent final presentation on her work in the lab with Dr. Avik Chattopadhyay and Erin O’Connor as part of the Summer Undergraduate Research Program (SURP)! #immunologymatters #changingwhatspossible

A new engineered regulatory T cell is born. Chimeric anti-HLA receptor regulatory T cells (CHAR Tregs) inhibit antibody production by B cells from HLA sensitized transplant patients, offering a precise approach to tackle antibody-mediated organ rejection. frontiersin.org/journals/immun…

MUSC researchers have engineered a new type of genetically modified immune cell that can precisely target and neutralize antibody-producing cells complicit in organ rejection. Learn More: web.musc.edu/about/news-cen…

Can we reengineer the transplant environment for beta-cell survival? Dr. Leonardo Ferreira (Medical University of South Carolina) explores immune-suppressive microenvironments to enhance success in T1D cell therapy. #ADA2025 🎥 Watch now on #VuMedi: tinyurl.com/398mp82y

🔟 𝗧𝗼𝗽 𝟭𝟬 𝗠𝘂𝘀𝘁-𝗥𝗲𝗮𝗱 𝗨𝗽𝗱𝗮𝘁𝗲𝘀 𝗶𝗻 𝗜𝗺𝗺𝘂𝗻𝗼-𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆 𝗧𝗵𝗶𝘀 𝗪𝗲𝗲𝗸 This Week’s Spotlight by OncoDaily Immuno-Oncology. From new engineered T cells transplant rejection treatments to the rapid response of next-gen CAR-T therapies in

School is back in session!!! The energy is palpable Medical University of South Carolina (MUSC)! PC: MUSC Grad Studies

The age of immunotherapy for type 1 diabetes is upon us! Thrilled by the opportunity to contribute to this review led by Remi Creusot Columbia University! #immunologymatters #endt1d sciencedirect.com/science/articl…

Repurposing cancer immunotherapies for use in autoimmunity and transplantation! Check out our special issue Frontiers - Immunology with articles by Aref, Biswas, Bonini, Bluestone, Brusko, Ferreira, Fousteri, Marshall, Skartsis, and Sugitani! #immunologymatters frontiersin.org/journals/immun…

Deeply honored to speak at the Tregs as Medicine Symposium in Tokyo celebrating Prof. Sakaguchi’s description of regulatory T cell (Tregs). A special meeting made even more timely by this morning’s news that Prof. Sakaguchi is a recipient of this year's Nobel Prize in Medicine!